Affluent Medical SAS Aktie
| 1,25EUR | -0,02EUR | -1,57% |
WKN DE: A3CRZT / ISIN: FR0013333077
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 50 | 59 | 63 | 77 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,05 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8 | 15 | 7 | 6 | 12 |
| Summe Anlagevermögen | 56 | 63 | 52 | 49 | 47 |
| Summe Aktiva | 65 | 70 | 60 | 57 | 61 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 21 | 20 | 18 | 17 | 16 |
| Summe Fremdkapital | 30 | 27 | 26 | 25 | 31 |
| Summe Eigenkapital | 35 | 44 | 34 | 31 | 30 |
| Summe Passiva | 65 | 70 | 60 | 57 | 61 |
Adresse
| 320, avenue Archimède Les pléiades, 13100 Aix-en-Provence | |
| Internet | http://www.affluentmedical.com |
Management
|
Benjamin Renault
Director-Research & Development |
|
Christophe Giot
Vice President-Clinical Affairs |
|
Claire André
Manager-Quality Assurance |
|
Claire Corot
Director |
|
Céline Buard
Director-Marketing |
|
Dominique Carouge
Director |
|
Ellen Roche
Director |
|
Eric Jague
Regulatory Affairs Director |
|
Federica Azzimonti
Director of Clinical Operations |
|
Francois Laborde
Medical Director |
|
Liane Teplitsky
Director |
|
Luc Parisot
Chief Financial Officer |
|
Michel Therin
Chairman |
|
Olivier Belamy
Director-Industrialization |
|
Olivier Pieron
Chief Operating Officer |
|
Patrick Coulombier
Director |
|
Philippe Pouletty
Director |
|
Soad El Ghazouani
Independent Director |
|
Sébastien Ladet
Chief Executive Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
